Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal

In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratified by age and population density. We found a seroprevalence of 2.2%, 3–4 times larger than the official number of cases at the end of the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Canto e Castro, Luísa, Pereira, Ana Helena Guia, Ribeiro, Rita, Alves, Catarina, Veloso, Luís, Vicente, Vera, Alves, Dalila, Domingues, Inês, Silva, Cláudia, Gomes, Andreia, Serrano, Marta, Afonso, Ângela, Veldhoen, Marc, de Sousa, Maria José Rego, de Sousa, José Germano Rego, de Sousa, Germano, Mota, Maria M., Silva-Santos, Bruno, Ribeiro, Ruy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544986/
https://www.ncbi.nlm.nih.gov/pubmed/34437830
http://dx.doi.org/10.3201/eid2711.210636
_version_ 1784589931706843136
author Canto e Castro, Luísa
Pereira, Ana Helena Guia
Ribeiro, Rita
Alves, Catarina
Veloso, Luís
Vicente, Vera
Alves, Dalila
Domingues, Inês
Silva, Cláudia
Gomes, Andreia
Serrano, Marta
Afonso, Ângela
Veldhoen, Marc
de Sousa, Maria José Rego
de Sousa, José Germano Rego
de Sousa, Germano
Mota, Maria M.
Silva-Santos, Bruno
Ribeiro, Ruy M.
author_facet Canto e Castro, Luísa
Pereira, Ana Helena Guia
Ribeiro, Rita
Alves, Catarina
Veloso, Luís
Vicente, Vera
Alves, Dalila
Domingues, Inês
Silva, Cláudia
Gomes, Andreia
Serrano, Marta
Afonso, Ângela
Veldhoen, Marc
de Sousa, Maria José Rego
de Sousa, José Germano Rego
de Sousa, Germano
Mota, Maria M.
Silva-Santos, Bruno
Ribeiro, Ruy M.
author_sort Canto e Castro, Luísa
collection PubMed
description In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratified by age and population density. We found a seroprevalence of 2.2%, 3–4 times larger than the official number of cases at the end of the first wave of the pandemic.
format Online
Article
Text
id pubmed-8544986
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-85449862021-11-06 Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal Canto e Castro, Luísa Pereira, Ana Helena Guia Ribeiro, Rita Alves, Catarina Veloso, Luís Vicente, Vera Alves, Dalila Domingues, Inês Silva, Cláudia Gomes, Andreia Serrano, Marta Afonso, Ângela Veldhoen, Marc de Sousa, Maria José Rego de Sousa, José Germano Rego de Sousa, Germano Mota, Maria M. Silva-Santos, Bruno Ribeiro, Ruy M. Emerg Infect Dis Dispatch In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratified by age and population density. We found a seroprevalence of 2.2%, 3–4 times larger than the official number of cases at the end of the first wave of the pandemic. Centers for Disease Control and Prevention 2021-11 /pmc/articles/PMC8544986/ /pubmed/34437830 http://dx.doi.org/10.3201/eid2711.210636 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Canto e Castro, Luísa
Pereira, Ana Helena Guia
Ribeiro, Rita
Alves, Catarina
Veloso, Luís
Vicente, Vera
Alves, Dalila
Domingues, Inês
Silva, Cláudia
Gomes, Andreia
Serrano, Marta
Afonso, Ângela
Veldhoen, Marc
de Sousa, Maria José Rego
de Sousa, José Germano Rego
de Sousa, Germano
Mota, Maria M.
Silva-Santos, Bruno
Ribeiro, Ruy M.
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
title Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
title_full Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
title_fullStr Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
title_full_unstemmed Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
title_short Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
title_sort prevalence of sars-cov-2 antibodies after first 6 months of covid-19 pandemic, portugal
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544986/
https://www.ncbi.nlm.nih.gov/pubmed/34437830
http://dx.doi.org/10.3201/eid2711.210636
work_keys_str_mv AT cantoecastroluisa prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT pereiraanahelenaguia prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT ribeirorita prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT alvescatarina prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT velosoluis prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT vicentevera prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT alvesdalila prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT dominguesines prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT silvaclaudia prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT gomesandreia prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT serranomarta prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT afonsoangela prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT veldhoenmarc prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT desousamariajoserego prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT desousajosegermanorego prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT desousagermano prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT motamariam prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT silvasantosbruno prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal
AT ribeiroruym prevalenceofsarscov2antibodiesafterfirst6monthsofcovid19pandemicportugal

Ejemplares similares